Atom Investors LP Merus N.V. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $1.06 Million - $1.61 Million	-26,744 Reduced 37.9%	43,827 $2.59 Million
Q1 2024 May 15, 2024	BUY	$28.03 - $51.82 $981,806 - $1.82 Million	35,027 Added 98.55%	70,571 $3.18 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $440,838 - $629,832	21,976 Added 161.97%	35,544 $977,000
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $273,123 - $370,270	13,568 New	13,568 $319,000

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.